Functional Characterization of N -acetyl- l -Leucyl- l -Lysine Supports a Peptide Prodrug Mechanism for TB-500
Biomaterials Research · 01.01.2026 · 30
DOI: 10.34133/bmr.0418 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomaterials Research, online erschienen am 30.09.2026. Verfasst von Khandoker Asiqur Rahaman und 15 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Korea Institute of Science and Technology.
Abstract (Originalsprache)
The therapeutic application of peptides has expanded considerably in clinical and regenerative medicine; however, the contribution of peptide metabolites to therapeutic efficacy remains poorly understood. We previously identified N -acetyl- l -leucyl- l -lysine (Ac-LK) as the major metabolite of TB-500 by metabolic profiling and hypothesized that it contributes to the biological activity of the parent peptide. Initial screening demonstrated that Ac-LK exhibited greater SARS-CoV-2 main protease inhibitory activity than TB-500, the other identified metabolites, and the constituent amino acids. We therefore systematically characterized Ac-LK using cellular uptake, endothelial cell functional assays, proteomic profiling, and in vivo wound healing. Under the experimental conditions employed, Ac-LK exhibited enhanced protection against hypoxia/reoxygenation-induced injury, stronger promigratory and barrier-stabilizing activities, broader regulation of pathways related to cytoskeletal organization, cadherin-mediated adhesion, and protein translation, and accelerated wound healing. Collectively, these findings identify Ac-LK as a biologically active metabolite of TB-500 and support the hypothesis that metabolic conversion contributes to the therapeutic actions of the parent peptide.
Förderung
- Korea Institute of Science and Technology
Zitieren
APA
Rahaman, K. A., Mukim, M. S. I., Hasan, M. L., Choi, S. J., Park, S., Kim, H., Jung, Y., Pan, C., Moon, S., Min, H., Kwon, O., Uddin, S., Jeon, H., Joung, Y. K., Song, D., & Ha, H. (2026). Functional Characterization of N -acetyl- l -Leucyl- l -Lysine Supports a Peptide Prodrug Mechanism for TB-500. Biomaterials Research, 30. https://doi.org/10.34133/bmr.0418
Vancouver
Rahaman KA, Mukim MSI, Hasan ML, Choi SJ, Park S, Kim H, et al. Functional Characterization of N -acetyl- l -Leucyl- l -Lysine Supports a Peptide Prodrug Mechanism for TB-500. Biomaterials Research. 2026;30. doi:10.34133/bmr.0418
BibTeX
@article{Rahaman2026,
author = {Rahaman, Khandoker Asiqur and Mukim, Md Sofequl Islam and Hasan, Md Lemon and Choi, Soon Jin and Park, Soyeon and Kim, Hyeok and Jung, Yuna and Pan, Cheol-Ho and Moon, Sung-Hwan and Min, Hophil and Kwon, Oh-Seung and Uddin, Shihab and Jeon, Hojeong and Joung, Yoon Ki and Song, Dae-Geun and Ha, Hyung-Seop},
title = {Functional Characterization of N -acetyl- l -Leucyl- l -Lysine Supports a Peptide Prodrug Mechanism for TB-500},
journal = {Biomaterials Research},
year = {2026},
volume = {30},
doi = {10.34133/bmr.0418}
}
EUVIMED